Latest PE Voice
Anki Forsberg, partner of HealthCap, gives her view on the Nordic biotech industry in 2009 and beyond
2009 – A changing industry and the industry of change
The falling markets and economic downturn has, after the smoke cleared, reformed the biomedical industry to one different from what it used to be. Biotech companies have been forced to downsize operations, cut costs, focus on core projects, choosing a cost-efficient development path and turn to alternative financing. Big Pharma...